Wall Street Futures Point to Fifth Consecutive Gain as AI Optimism and Lower Oil Prices Support Sentiment Rising Inflation Spreads Beyond Iran Tensions and Oil Prices Affecting Broader Consumer Goods Can You Use a Credit Card at an ATM What to Know About Cash Advances and Fees Oil Price Plunge and SP 500 Record High Bitcoins Correlation Dynamics in Focus Companies Double Down on Prediction Market Investments Amid Regulatory Uncertainty European Officials See Extended Energy Price Pressures Through 2027 DXPE Q1 2026 Earnings EPS Misses Estimates Stock Declines 154 TransCode Therapeutics Q4 2024 Earnings Deep Losses Reflect PreRevenue Stage SYRE Q1 2026 Earnings WiderthanExpected Loss Highlights Development Stage Challenges Symbotic Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Growth Optimism PSEC Q1 2026 Earnings Earnings Miss Estimates Stock Gains Marginally Post Holdings Q1 2026 Earnings Strong EPS Beat Amid Unclear Revenue Picture BNY Mellon Strategic Municipal Bond Fund DSM holds steady near support with minor uptick Rio Tinto Surges 238 Testing Resistance at 11205 Amid Strong Momentum Sunstone Hotel Investors SHO Rises Modestly Tests Key Resistance Near 1125 United Therapeutics UTHR Slips 133 as Stock Holds Above Key Support Great Lakes Dredge Dock Corporation GLDD Consolidates at 1700 as Market Awaits Catalyst Micron Technology Achieves 1 Trillion Market Cap Milestone Amid AIDriven Memory Demand MSCI Q1 2026 Earnings Slight EPS Beat Supports Positive Market Response 51Talk COE Holds Near 263 After Marginal Decline Key Support at 2498 in Focus CW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Rimini Street Inc RMNI Q1 2026 Earnings Earnings Per Share Misses Estimates Amid Limited Revenue Disclosure NIQ Q1 2026 Earnings EPS Beats Estimates by 476 Amid Strong Operational Execution ZD Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Progress OOMA Q1 2026 Earnings EPS Surpasses Estimates with 786 Beat FMC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Challenges MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress